What if you could see your manufacturing potential and determine your cell and gene therapy strategy before making a large capital investment? Whether it’s a unit operation, single process train or entire manufacturing plant, new technologies allow companies to study and validate potential processes earlier than ever before.
On Wednesday, September 25th, Nicolas Lehle presented “Try Before You Buy – Simulation for Cell and Gene Therapy Facilities at the 2019 ILMAC conference in Basel, Switzerland.
The presentation covered the different ways companies can utilize process simulation to see multiple design scenarios and determine manufacturing capacity.
If you missed the presentation and would like to learn more, you can download it here.
Have a question about process simulation for your next project in Europe? Email us at .